• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用一项基于医院的前瞻性队列研究开发2型糖尿病患者7年和10年全因死亡风险预测模型。

Developing a Prediction Model for 7-Year and 10-Year All-Cause Mortality Risk in Type 2 Diabetes Using a Hospital-Based Prospective Cohort Study.

作者信息

Chiu Sherry Yueh-Hsia, Chen Ying Isabel, Lu Juifen Rachel, Ng Soh-Ching, Chen Chih-Hung

机构信息

Department of Health Care Management, College of Management, Chang Gung University, Taoyuan 33302, Taiwan.

Healthy Aging Research Center, Chang Gung University, Taoyuan 33302, Taiwan.

出版信息

J Clin Med. 2021 Oct 18;10(20):4779. doi: 10.3390/jcm10204779.

DOI:10.3390/jcm10204779
PMID:34682901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8537078/
Abstract

Leveraging easily accessible data from hospitals to identify high-risk mortality rates for clinical diabetes care adjustment is a convenient method for the future of precision healthcare. We aimed to develop risk prediction models for all-cause mortality based on 7-year and 10-year follow-ups for type 2 diabetes. A total of Taiwanese subjects aged ≥18 with outpatient data were ascertained during 2007-2013 and followed up to the end of 2016 using a hospital-based prospective cohort. Both traditional model selection with stepwise approach and LASSO method were conducted for parsimonious models' selection and comparison. Multivariable Cox regression was performed for selected variables, and a time-dependent ROC curve with an integrated AUC and cumulative mortality by risk score levels was employed to evaluate the time-related predictive performance. The prediction model, which was composed of eight influential variables (age, sex, history of cancers, history of hypertension, antihyperlipidemic drug use, HbA1c level, creatinine level, and the LDL /HDL ratio), was the same for the 7-year and 10-year models. Harrell's C-statistic was 0.7955 and 0.7775, and the integrated AUCs were 0.8136 and 0.8045 for the 7-year and 10-year models, respectively. The predictive performance of the AUCs was consistent with time. Our study developed and validated all-cause mortality prediction models with 7-year and 10-year follow-ups that were composed of the same contributing factors, though the model with 10-year follow-up had slightly greater risk coefficients. Both prediction models were consistent with time.

摘要

利用医院易于获取的数据来识别临床糖尿病护理调整的高风险死亡率,是精准医疗未来的一种便捷方法。我们旨在基于2型糖尿病的7年和10年随访结果,开发全因死亡率的风险预测模型。在2007年至2013年期间确定了共有年龄≥18岁且有门诊数据的台湾受试者,并使用基于医院的前瞻性队列随访至2016年底。采用逐步法的传统模型选择和LASSO方法进行简约模型的选择和比较。对选定变量进行多变量Cox回归,并采用具有综合AUC和按风险评分水平计算的累积死亡率的时间依赖性ROC曲线来评估时间相关的预测性能。由八个有影响的变量(年龄、性别、癌症病史、高血压病史、使用抗高脂血症药物、糖化血红蛋白水平、肌酐水平以及低密度脂蛋白/高密度脂蛋白比值)组成的预测模型,在7年和10年模型中是相同的。7年和10年模型的Harrell's C统计量分别为0.7955和0.7775,综合AUC分别为0.8136和0.8045。AUC的预测性能与时间一致。我们的研究开发并验证了具有7年和10年随访的全因死亡率预测模型,这些模型由相同的影响因素组成,尽管10年随访模型的风险系数略高。两个预测模型都与时间一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/8f4a35a2952c/jcm-10-04779-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/0d678dadfba5/jcm-10-04779-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/6e8cbde456a5/jcm-10-04779-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/0c12dacb3e24/jcm-10-04779-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/8f4a35a2952c/jcm-10-04779-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/0d678dadfba5/jcm-10-04779-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/6e8cbde456a5/jcm-10-04779-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/0c12dacb3e24/jcm-10-04779-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63d2/8537078/8f4a35a2952c/jcm-10-04779-g004.jpg

相似文献

1
Developing a Prediction Model for 7-Year and 10-Year All-Cause Mortality Risk in Type 2 Diabetes Using a Hospital-Based Prospective Cohort Study.利用一项基于医院的前瞻性队列研究开发2型糖尿病患者7年和10年全因死亡风险预测模型。
J Clin Med. 2021 Oct 18;10(20):4779. doi: 10.3390/jcm10204779.
2
Predicting 1-, 3-, 5-, and 8-year all-cause mortality in a community-dwelling older adult cohort: relevance for predictive, preventive, and personalized medicine.预测社区居住老年人群队列中1年、3年、5年和8年全因死亡率:对预测性、预防性和个性化医学的意义。
EPMA J. 2023 Nov 3;14(4):713-726. doi: 10.1007/s13167-023-00342-4. eCollection 2023 Dec.
3
Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.用于估计2型糖尿病未来风险的QDiabetes-2018风险预测算法的开发与验证:队列研究
BMJ. 2017 Nov 20;359:j5019. doi: 10.1136/bmj.j5019.
4
ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study.中国多中心慢性肾脏病队列中的终末期肾病风险预测模型:一项推导、验证及比较研究
J Clin Med. 2023 Feb 14;12(4):1504. doi: 10.3390/jcm12041504.
5
Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods.应用基于可解释机器学习的方法建立并验证中国基层医疗机构 2 型糖尿病患者心血管疾病 10 年风险预测模型。
Diabetes Obes Metab. 2024 Sep;26(9):3969-3987. doi: 10.1111/dom.15745. Epub 2024 Jul 15.
6
Development and validation of a risk prediction model for chronic kidney disease among individuals with type 2 diabetes.开发和验证 2 型糖尿病患者慢性肾脏病风险预测模型。
Sci Rep. 2022 Mar 21;12(1):4794. doi: 10.1038/s41598-022-08284-z.
7
Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.预测肺癌未来风险:CanPredict(肺部)模型在 1967 万人中的开发、内部和外部验证以及该模型与其他七个风险预测模型的性能评估。
Lancet Respir Med. 2023 Aug;11(8):685-697. doi: 10.1016/S2213-2600(23)00050-4. Epub 2023 Apr 5.
8
Development and visualization of a risk prediction model for metabolic syndrome: a longitudinal cohort study based on health check-up data in China.代谢综合征风险预测模型的建立与可视化:基于中国健康体检数据的纵向队列研究
Front Nutr. 2023 Nov 21;10:1286654. doi: 10.3389/fnut.2023.1286654. eCollection 2023.
9
Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.基于人群的回顾性队列研究:为中国 2 型糖尿病患者开发心血管疾病风险预测模型和工具。
Diabetes Obes Metab. 2018 Feb;20(2):309-318. doi: 10.1111/dom.13066. Epub 2017 Aug 25.
10
Development and validation of a simple and practical model for early detection of diabetic macular edema in patients with type 2 diabetes mellitus using easily accessible systemic variables.开发并验证了一种简单实用的模型,可使用易于获得的系统变量早期检测 2 型糖尿病患者的糖尿病性黄斑水肿。
J Transl Med. 2024 May 31;22(1):523. doi: 10.1186/s12967-024-05328-y.

引用本文的文献

1
Photoreceptor metabolic window unveils eye-body interactions.光感受器代谢窗口揭示眼-身相互作用。
Nat Commun. 2025 Jan 15;16(1):697. doi: 10.1038/s41467-024-55035-x.
2
Predictive models and determinants of mortality among T2DM patients in a tertiary hospital in Ghana, how do machine learning techniques perform?加纳一家三级医院中2型糖尿病患者的死亡率预测模型及决定因素,机器学习技术表现如何?
BMC Endocr Disord. 2025 Jan 10;25(1):9. doi: 10.1186/s12902-025-01831-5.
3
Development and validation of a nomogram of all-cause mortality in adult Americans with diabetes.

本文引用的文献

1
Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.按绩效付费计划可降低2型糖尿病患者的中风风险:一项全国队列研究。
BMJ Open. 2019 Oct 16;9(10):e026626. doi: 10.1136/bmjopen-2018-026626.
2
Trends of mortality in diabetic patients in Taiwan: A nationwide survey in 2005-2014.台湾地区糖尿病患者死亡率趋势:2005-2014 年全国性调查。
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S83-S89. doi: 10.1016/j.jfma.2019.07.008. Epub 2019 Jul 24.
3
Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model.
开发并验证了一个针对美国成年糖尿病患者全因死亡率的列线图。
Sci Rep. 2024 Aug 19;14(1):19148. doi: 10.1038/s41598-024-69581-3.
4
Development and validation of questionnaire-based machine learning models for predicting all-cause mortality in a representative population of China.基于问卷的机器学习模型的开发和验证,用于预测中国代表性人群的全因死亡率。
Front Public Health. 2023 Jan 27;11:1033070. doi: 10.3389/fpubh.2023.1033070. eCollection 2023.
5
Developing a prediction model for all-cause mortality risk among patients with type 2 diabetes mellitus in Shanghai, China.建立中国上海 2 型糖尿病患者全因死亡率风险预测模型。
J Diabetes. 2023 Jan;15(1):27-35. doi: 10.1111/1753-0407.13343. Epub 2022 Dec 16.
2 型糖尿病患者死亡率风险估计(ENFORCE):一个廉价且简约的预测模型。
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4900-4908. doi: 10.1210/jc.2019-00215.
4
Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants.亚洲人群中糖尿病与全因及特定原因死亡率的相关性:一项超过 100 万参与者的汇总分析。
JAMA Netw Open. 2019 Apr 5;2(4):e192696. doi: 10.1001/jamanetworkopen.2019.2696.
5
Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis.他汀类药物对心血管和全因死亡率的遗留效应:荟萃分析。
BMJ Open. 2018 Oct 4;8(9):e020584. doi: 10.1136/bmjopen-2017-020584.
6
Development and validation of prediction models for the risks of diabetes-related hospitalization and in-hospital mortality in patients with type 2 diabetes.开发和验证 2 型糖尿病患者糖尿病相关住院和住院死亡率风险预测模型。
Metabolism. 2018 Aug;85:38-47. doi: 10.1016/j.metabol.2018.02.003. Epub 2018 Feb 13.
7
Effects of statins on all-cause mortality at different low-density-lipoprotein cholesterol levels in Asian patients with type 2 diabetes.他汀类药物对不同低密度脂蛋白胆固醇水平的亚洲 2 型糖尿病患者全因死亡率的影响。
Curr Med Res Opin. 2018 Nov;34(11):1885-1892. doi: 10.1080/03007995.2018.1439829. Epub 2018 Mar 12.
8
Developing an adequate supply of health services: Taiwan's path to Universal Health Coverage.发展充足的卫生服务供应:台湾实现全民健康覆盖的路径。
Soc Sci Med. 2018 Feb;198:7-13. doi: 10.1016/j.socscimed.2017.12.017. Epub 2017 Dec 15.
9
Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.他汀类药物的使用可降低中国2型糖尿病患者的心血管事件及全因死亡率:一项5年队列研究。
BMC Cardiovasc Disord. 2017 Jun 24;17(1):166. doi: 10.1186/s12872-017-0599-x.
10
The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.全球 20-79 岁成年人糖尿病的经济负担:疾病成本研究。
Lancet Diabetes Endocrinol. 2017 Jun;5(6):423-430. doi: 10.1016/S2213-8587(17)30097-9. Epub 2017 Apr 26.